Patents by Inventor Anuradha Gore

Anuradha Gore has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR TREATMENT OF PRESBYOPIA
    Publication number: 20220273605
    Abstract: The present invention is related to topical ophthalmic compositions comprising one or more active components. The active components in the topical ophthalmic compositions include, but are not limited to carbachol, phospholine iodide and pharmaceutically acceptable salts thereof. Also described herein are methods for the treatment of presbyopia, methods for improving near vision in a subject with presbyopia, and methods for reducing pupil diameter in a subject with presbyopia using the topical ophthalmic compositions.
    Type: Application
    Filed: July 24, 2020
    Publication date: September 1, 2022
    Inventors: Michael R. Robinson, Mohammed Dibas, Anuradha Gore
  • PRESBYOPIA TREATMENTS
    Publication number: 20220241245
    Abstract: Described herein are methods and compositions for the treatment of ocular conditions and for the improvement of vision parameters using pharmaceutically acceptable ophthalmic pilocarpine formulations. A nonlimiting example of an ocular condition that may be treated with the methods and compositions disclosed herein is presbyopia.
    Type: Application
    Filed: January 12, 2022
    Publication date: August 4, 2022
    Inventors: Michael R. Robinson, Mohammed Dibas, Jaya Giyanani, Anuradha Gore, Sungwook Lee, Haixia Liu, Aileen Morgan, Jihao Zhou
  • Presbyopia treatments
    Patent number: 11285134
    Abstract: Described herein are methods and compositions for the treatment of ocular conditions and for the improvement of vision parameters using pharmaceutically acceptable ophthalmic pilocarpine formulations. A nonlimiting example of an ocular condition that may be treated with the methods and compositions disclosed herein is presbyopia.
    Type: Grant
    Filed: February 14, 2020
    Date of Patent: March 29, 2022
    Assignee: ALLERGAN, INC.
    Inventors: Michael R. Robinson, Mohammed Dibas, Jaya Giyanani, Anuradha Gore, Sungwook Lee, Haixia Liu, Aileen Morgan, Jihao Zhou
  • PRESBYOPIA TREATMENTS
    Publication number: 20210008034
    Abstract: Described herein are methods and compositions for the treatment of ocular conditions and for the improvement of vision parameters using pharmaceutically acceptable ophthalmic pilocarpine formulations. A nonlimiting example of an ocular condition that may be treated with the methods and compositions disclosed herein is presbyopia.
    Type: Application
    Filed: February 14, 2020
    Publication date: January 14, 2021
    Inventors: Michael R. Robinson, Mohammed Dibas, Jaya Giyanani, Anuradha Gore, Sungwook Lee, Haixia Liu, Aileen Morgan, Jihao Zhou
  • Presbyopia treatments
    Patent number: 10610518
    Abstract: Described herein are methods and compositions for the treatment of ocular conditions and for the improvement of vision parameters using pharmaceutically acceptable ophthalmic pilocarpine formulations. A nonlimiting example of an ocular condition that may be treated with the methods and compositions disclosed herein is presbyopia.
    Type: Grant
    Filed: April 24, 2019
    Date of Patent: April 7, 2020
    Assignee: ALLERGAN, INC.
    Inventors: Michael R. Robinson, Mohammed Dibas, Jaya Giyanani, Anuradha Gore, Sungwook Lee, Haixia Liu, Aileen Morgan, Jihao Zhou
  • PRESBYOPIA TREATMENTS
    Publication number: 20190321337
    Abstract: Described herein are methods and compositions for the treatment of ocular conditions and for the improvement of vision parameters using pharmaceutically acceptable ophthalmic pilocarpine formulations. A nonlimiting example of an ocular condition that may be treated with the methods and compositions disclosed herein is presbyopia.
    Type: Application
    Filed: April 24, 2019
    Publication date: October 24, 2019
    Inventors: Michael R. Robinson, Mohammed Dibas, Jaya Giyanani, Anuradha Gore, Sungwook Lee, Haixia Liu, Aileen Morgan, Jihao Zhou
  • Suspensions of cyclosporin A form 2
    Patent number: 8796222
    Abstract: Disclosed herein are methods of formulating cyclosporin A Form 2.
    Type: Grant
    Filed: November 14, 2012
    Date of Patent: August 5, 2014
    Assignee: Allergan, Inc.
    Inventors: Anuradha Gore, Prem Swaroop Mohanty, E. Quinn Farnes
  • Stable emulsion formulations
    Patent number: 8779004
    Abstract: The present invention relates to injectable formulations of irritant agents, such as calcimimetics, that are pharmaceutically stable and demonstrate a reduced incidence of irritation, pain, phlebitis, precipitation and hemolysis upon injection.
    Type: Grant
    Filed: April 20, 2007
    Date of Patent: July 15, 2014
    Assignee: Amgen, Inc.
    Inventors: Anuradha Gore, Anne Navratil, Seshadri Neervannan, Christopher W. Spancake, Roger Zanon
  • SUSPENSIONS OF CYCLOSPORIN A FORM 2
    Publication number: 20130122059
    Abstract: Disclosed herein are methods of formulating cyclosporin A Form 2.
    Type: Application
    Filed: November 14, 2012
    Publication date: May 16, 2013
    Applicant: ALLERGAN, INC.
    Inventors: Anuradha Gore, Prem Swaroop Mohanty, E. Quinn Farnes
  • CYCLOSPORIN EMULSIONS
    Publication number: 20110294744
    Abstract: Disclosed herein is a composition comprising cyclosporin A at a concentration between about 0.001% (w/v) and about 1.0% (w/v), a plant oil at a concentration between about 0.01% (w/v) and about 10% (w/v), and macrogol 15 hydroxystearate at a concentration between about 0.01% (w/v) and about 10% (w/v).
    Type: Application
    Filed: May 25, 2011
    Publication date: December 1, 2011
    Inventors: Aileen Morgan, Anuradha Gore, Mayssa Attar
  • STABLE EMULSION FORMULATIONS
    Publication number: 20070249520
    Abstract: The present invention relates to injectable formulations of irritant agents, such as calcimimetics, that are pharmaceutically stable and demonstrate a reduced incidence of irritation, pain, phlebitis, precipitation and hemolysis upon injection.
    Type: Application
    Filed: April 20, 2007
    Publication date: October 25, 2007
    Applicant: AMGEN INC.
    Inventors: Anuradha Gore, Anne Navratil, Seshadri Neervannan, Christopher Spancake, Roger Zanon